Patients With IBD Receiving Methotrexate Are at Higher Risk of Liver Injury Compared With Patients With Non-IBD Diseases: A Meta-Analysis and Systematic Review
2021 · Frontiers in Medicine · 17 citations
https://doi.org/10.3389/fmed.2021.774824
Z
Ziliang Ke
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
100
Citations
4
h-index
4
i10-index
Ziliang Ke is an academic researcher from Peking University. The author has contributed to research in topics: Liver Diseases and Immunity & Gut microbiota and health & Liver Disease Diagnosis and Treatment. The author has an h-index of 4, co-authored 8 publications.
ORCID: 0000-0002-2461-2410Papers by this author
works<i>Escherichia coli</i> NF73‐1 disrupts the gut–vascular barrier and aggravates high‐fat diet‐induced fatty liver disease via inhibiting Wnt/β‐catenin signalling pathway
2024 · Liver International · 17 citations
https://doi.org/10.1111/liv.15823
The oral bacterial microbiota facilitates the stratification for ulcerative colitis patients with oral ulcers
2023 · Annals of Clinical Microbiology and Antimicrobials · 11 citations
https://doi.org/10.1186/s12941-023-00646-3
<scp>HFD</scp> Exacerbates Hepatic Lipid Metabolism Disorders After Cholecystectomy by Regulating the Bile Acid and Neutrophil Recruitment
2025 · Liver International · 1 citations
https://doi.org/10.1111/liv.70130
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat